Ulipristal Acetate

Spezifikationen

126784-99-4CAS-Nummer

682-170-1EG-Nummer

[(8S,11R,13S,14S,17R)-17-acetyl-11-[4-(dimethylamino)phenyl]-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetateIUPAC-Name

C30H37NO4Chemische Formel

475.6 g/molMolekulargewicht

Ulipristal acetate; 126784-99-4; Ella; EllaOne; CDB-2914; VA2914; YF7V70N02B; (11beta)-17-(Acetyloxy)-11-[4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione; RTI-3021-012; PGL-4001; VA-2914; 17-Acetoxy-11-(4-N,N-dimethylaminophenyl)pregna-4,9-diene-3,20-dione; CHEBI:71025; DTXSID30155294; (11beta)-17-(Acetyloxy)-11-(4-(dimethylamino)phenyl)-19-norpregna-4,9-diene-3,20-dione; Esmya; 17beta-acetyl-11beta-[4-(dimethylamino)phenyl]-3-oxoestra-4,9-dien-17alpha-yl acetate; [(8S,11R,13S,14S,17R)-17-acetyl-11-(4-dimethylaminophenyl)-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate; 17beta-acetyl-11beta-(4-(dimethylamino)phenyl)-3-oxoestra-4,9-dien-17alpha-yl acetate; ((8S,11R,13S,14S,17R)-17-acetyl-11-(4-dimethylaminophenyl)-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta(a)phenanthren-17-yl) acetate; LOGILIA; RefChem:56802; DTXCID9077785; 17-alpha-acetoxy-11-beta-(4-dimethylaminophenyl)-19-norpregna-4,9-dien-3,20-dione; 11-beta-17-(acetyloxy)-11-(4-(dimethylamino)phenyl)-19-norpregna-4,9-diene-3,20-dione; CDB 2914; Ulipristal acetate [USAN]; MFCD00899035; Ulipristal acetate(CDB2914); (8S,11R,13S,14S,17R)-17-acetyl-11-(4-(dimethylamino)phenyl)-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate; [(8s,11r,13s,14s,17r)-17-Acetyl-11-[4-(Dimethylamino)phenyl]-13-Methyl-3-Oxo-1,2,6,7,8,11,12,14,15,16-Decahydrocyclopenta[a]phenanthren-17-Yl] Acetate; (1R,3aS,3bS,10R,11aS)-1-acetyl-10-[4-(dimethylamino)phenyl]-11a-methyl-7-oxo-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl acetate; C30H37NO4; (11beta,17alpha)-17-acetyl-11-[4-(dimethylamino)phenyl]-3-oxoestra-4,9-dien-17-yl acetate; Hrp-2000; UNII-YF7V70N02B; Ulipristal acet; Ulipristal?; 4oar; Ella norpregnadiene; (8S,11R,13S,14S,17R)-17-Acetyl-11-[4-(dimethylamino)phenyl]-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl Acetate; CBD 2914; Ella (TN); RTI 3021-012; SCHEMBL544957; Ulipristal acetate (Standard); CHEMBL260538; GTPL7460; orb1305355; ULIPRISTAL ACETATE [MI]; Ulipristal acetate (JAN/USAN); ULIPRISTAL ACETATE [JAN]; ta[a]phenanthren-17-yl] acetate; (11|A)-17-(Acetyloxy)-11-[4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione; ULIPRISTAL ACETATE [VANDF]; ULIPRISTAL ACETATE [MART.]; ULIPRISTAL ACETATE [WHO-DD]; BDBM50375424; EBC-07665; HY-16508R; Ulipristal acetate, >=98% (HPLC); AKOS026750526; CCG-269500; CS-1157; ULIPRISTAL ACETATE [ORANGE BOOK]; NCGC00378913-02; AS-73950; BU161520; HY-16508; SY028095; NS00002655; U0102; C72119; D09687; EN300-220766; AB01566874_01; F826247; Q975059; BRD-K64381438-001-03-8; Z2185283535; (11|_)-17-(Acetyloxy)-11-[4-(dimethylamino)phenyl]-19-norpregna-4,9-diene-3,20-dione; 11beta-[4-(Dimethylamino)phenyl]-3,20-dioxo-19-norpregna-4,9-dien-17-yl acetate; (11.BETA.)-17-(ACETYLOXY)-11-(4-(DIMETHYLAMINO)PHENYL)-19-NORPREGNA-4,9-DIENE-3,20-DIONE; (11alpha,13alpha,17beta)-17-acetyl-11-[4-(dimethylamino)phenyl]-3-oxoestra-4,9-dien-17-yl acetate; (8S,11R,13S,14S,17R)-17-acetyl-11-(4-(dimethylamino)phenyl)-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylacetate; [(8S,11R,13S,14S,17R)-17-acetyl-11-[4-(dimethylamino)phenyl]-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopen; 17.ALPHA.-ACETOXY-11.BETA.-(4-DIMETHYLAMINOPHENYL)-19-NORPREGNA-4,9-DIEN-3,20-DIONE; 19-Norpregna-4,9-diene-3,20-dione, 17-(acetyloxy)-11-(4-(dimethylamino)phenyl)-, (11beta)-Synonyme